Idris Syed: Presenting Our Omics and VTE Research at ISTH 2026
Idris Syed, Medical Assistant at Surgical Specialties, Medical Assistant at CHA Cambridge Pediatrics, Undergraduate Researcher, shared a post on LinkedIn:
“I’m grateful to have had the opportunity to attend the ISTH 2026 Congress in Paris and present our poster, ‘A Systematic Review of Omics-based Technologies in Venous Thromboembolism.’
This project examined how omics technologies have been applied to venous thromboembolism research and highlighted opportunities for future multi-omics approaches.
Beyond presenting our work, it was exciting to meet researchers and clinicians from around the world, learn about the latest advances in thrombosis and hemostasis, and bring home new ideas for future research.
A sincere thank you to Dr. Christopher Kabrhel , Dr. Drew Birrenkott, MD, DPhil, and Matthew Freitas for their mentorship throughout this project, and to everyone at the Center For Vascular Emergencies for making this opportunity possible.”
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
-
Sep 9, 2026, 16:07Zahra Safarzadeh: From Novel F8 Variant to Clinical Significance
-
Sep 9, 2026, 16:00Maximo Agustin Schiavone: HDL Beyond Cholesterol – Linking Lipids and Immunity
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk